Piracetam 1200mg Tablets

Piracetam 1200mg Tablets are a generic version of Nootropil® 1200mg, containing 1200mg of piracetam per tablet. Nootropil is a prescription medicine containing piracetam, a pyrrolidone derivative classified pharmacologically as a nootropic. Current UK product information specifies its use in adults with myoclonus of cortical origin, in combination with other anti-myoclonic therapies. Approved indications can differ between countries.

Product Information

Generic Name

Piracetam

Brand Reference

Nootropil® 1200mg

Strength

1200mg

Dosage Form

Film-Coated Tablet

Drug Class

Pyrrolidone Derivative / Nootropic

Active Ingredient

Piracetam 1200mg per tablet

Route

Oral

Prescription

Varies by country; UK Nootropil is prescription-only

Generic Status

Generic equivalent of Nootropil® 1200mg

Pack Size

Varies by manufacturer and market

Manufacturer

Varies according to the generic product

Market Authorization

Depends on the exact manufacturer and destination country

Generic Nootropil® 1200mg

Nootropil® is a brand containing piracetam. A generic piracetam 1200mg tablet contains the same active pharmaceutical ingredient and strength as a 1200mg piracetam reference product, but the manufacturer, inactive ingredients, tablet appearance and packaging can differ.

The current UK medicines database lists Nootropil 1200mg and Nootropil 800mg as piracetam products from ADVANZ Pharma.

Piracetam 1200mg and Kidney Function

Piracetam is eliminated predominantly through the kidneys. The UK product information therefore includes renal-function precautions and recommends dose adjustment in patients with renal impairment. Severe renal impairment is listed as a contraindication for the UK Nootropil product.

Piracetam 1200mg in the United States

Piracetam should not be presented as an FDA-approved drug in the United States. FDA records identify piracetam as not FDA approved for the orphan indications that have been designated, and FDA enforcement materials have specifically identified piracetam among racetam products that were not approved for sale as drugs in the United States.

Accordingly, U.S. availability and importation should not be described as equivalent to a standard FDA-approved prescription product.

International Availability

Piracetam and Nootropil products are marketed in different countries, but regulatory status, approved indications, prescription requirements, manufacturers and pack sizes vary considerably.

For example, current Russian pharmacy listings show Nootropil 1200mg film-coated tablets, 20 tablets, containing piracetam and marked as prescription medicine.

How it works

The precise mechanism of piracetam in cortical myoclonus has not been fully established. UK prescribing information describes pharmacological effects involving blood-cell and platelet properties, while stating that its mode of action in cortical myoclonus remains unknown.

Piracetam is used for specific neurological conditions depending on the country's approved product information. The current UK Nootropil 1200mg indication is cortical myoclonus in adults, used together with other anti-myoclonic treatments.

Because indications vary by jurisdiction, piracetam should not be marketed universally as a medicine for memory enhancement, concentration, studying, dementia or general cognitive improvement.

Piracetam can affect platelet aggregation and may increase bleeding risk in susceptible patients. Particular caution is advised in people with bleeding disorders, a history of haemorrhagic cerebrovascular events, gastrointestinal ulceration, those undergoing major surgery, or those taking anticoagulant or antiplatelet medicines.

The UK product information also lists hypersensitivity, severe renal impairment, cerebral haemorrhage and Huntington's disease among contraindications.